15 year experience of tacrolimus application in medical practice

Kondratyeva, Y. S.; Кондратьева, Ю. С.; Kokina, O. A.; Vedler, A. A.

doi:10.25208/0042-4609-2016-92-5-63-71

Vestnik dermatologii i venerologii

2016

DOI: 10.25208/0042-4609-2016-92-5-63-71

|View full text |Cite

15 year experience of tacrolimus application in medical practice

Y. S. Kondratyeva

Ю. С. Кондратьева²,

O. A. Kokina

et al.

Abstract: The review presents modern literature data on the use of tacrolimus in medical practice. The results of national and international research on the effectiveness and safety of the drug at various dermatoses are presented.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

2021

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Tacrolimus in pathogenetic therapy of chronic dermatoses

Филимонкова¹,

Колбина²

2018

Klin. dermatol. venerol.

View full text Add to dashboard Cite

Приведены данные зарубежных и отечественных клинических исследований по изучению эффективности и безопасности топических ингибиторов кальциневрина (ТИК) в лечении атопического дерматита и других хронических дерматозов. Представлены основные механизмы действия ТИК и преимущества препарата группы ТИК такролимуса. Такропик (0,1 и 0,03% мазь такролимуса)-топическое средство для лечения атопического дерматита средней и тяжелой степени у взрослых и детей. Ключевые слова: топические ингибиторы кальциневрина, такролимус, атопический дерматит, топическая терапия хронических дерматозов, клинические исследования, Такропик.

show abstract

Tacrolimus in pathogenetic therapy of chronic dermatoses

Филимонкова¹,

Колбина²

2018

Klin. dermatol. venerol.

View full text Add to dashboard Cite

show abstract

Effectiveness evaluation of the proactive maintenance therapy of atopic dermatitis in children using optical coherence tomography and skin ultrasound

Zaynullina¹,

Хисматуллина²,

Pechkurov³

2021

Klin. dermatol. venerol.

View full text Add to dashboard Cite

Combined pathogenetic therapy of allergic dermatoses in children

et al. 2021

View full text Add to dashboard Cite

Allergodermatoses make up the majority of allergic skin diseases in childhood, have a recurrent course and significantly disrupt the quality of life of patients and their families. The constant use of emollients, allowing to lengthen periods of remission and reduce the need for topical drugs, is associated with defects in the skin barrier function. Treatment with topical glucocorticosteroids (TCS) and topical calcineurin inhibitors (TCI), which are the basis of pharmacotherapy, should be carried out differentially, taking into account the localization, stage and activity of the inflammatory process, the area of the lesion, the age of the child and the multifactorial genesis of the disease. The basic principles of rational local therapy include the choice of the degree of activity of the drug, its concentration, dosage form, dosage frequency, duration of use to obtain a therapeutic effect and minimize side effects. In case of severe exacerbation and localization of inflammatory elements on the body and limbs in children, it is necessary to start treatment with class 2–3 THCS. When the process is localized on the face and other sensitive areas of the skin (neck and large folds), it is recommended to use class 7 TCS or give preference to TCI. The duration of a continuous course of TCS therapy in children depends on the severity of the exacerbation and should not exceed 2 weeks. The most effective way to reduce the course steroid load and avoid side effects is the early and correct use of TCS during an exacerbation. The advantages of TCI in comparison with TCS are the low incidence of side effects, the absence of contraindications for use on sensitive skin areas, and the possibility of longer use. The article contains Russian and foreign literature data on the use of THCS and TEC in the treatment of allegodermatosis in children and our own clinical observations of the effectiveness of the use of combination therapy: Comfoderm K cream (methylprednisolone aceponate with ceramides in the base), 0.03% tacrolimus ointment and emollient means - special cream Sensoderm with physiological lipids omega 3–6–9.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

15 year experience of tacrolimus application in medical practice

Abstract: The review presents modern literature data on the use of tacrolimus in medical practice. The results of national and international research on the effectiveness and safety of the drug at various dermatoses are presented.

Cited by 3 publications

References 56 publications

Tacrolimus in pathogenetic therapy of chronic dermatoses

Tacrolimus in pathogenetic therapy of chronic dermatoses

Effectiveness evaluation of the proactive maintenance therapy of atopic dermatitis in children using optical coherence tomography and skin ultrasound

Combined pathogenetic therapy of allergic dermatoses in children

Contact Info

Product

Resources

About